HomeInsights
INDUSTRY:
Pharma
TOPIC:
Regulatory & Legal, Manufacturers & Providers
TITLE:
EMA: Modelling and simulation in the development of medicines
BRIEF:
As per a press communique recently issued by EMA, a workshop on the use of innovative modelling and simulation approaches during the development and regulatory assessment of medicines will take place at the European Medicines Agency (EMA) on 21 November 2016.
LEGAL IMPLICATIONS:
BUSINESS IMPLICATIONS:
